Evidence map›Paper›PMID 28801309›Full record

Trial reportJournal of investigative medicine : the official publication of the American Federation for Clinical Research2018

Determining the mechanisms of dietary turnip rapeseed oil on cholesterol metabolism in men with metabolic syndrome.

Harri Juhani Saarinen, Chaiyasit Sittiwet, Piia Simonen, Markku J Nissinen, Ulf-Håkan Stenman, Helena Gylling, Ari Palomäki

Registry-linked trialOpen access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01119690 (Hämeenlinna Metabolic Syndrome Research Program), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01119690 nacompletednot on this map

Hämeenlinna Metabolic Syndrome Research Program (HMS): Effects of Dietary Cold-pressed Turnip Rapeseed Oil and Milk Fat on Serum Lipids, Oxidized LDL, Arterial Elasticity and Platelet Function

TypeinterventionalSponsorKanta-Häme Central HospitalRan2004 to 2008Enrolled43ConditionsMetabolic SyndromeArmsCold-pressed turnip rapeseed oil (CTPRO), milk fat
3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. The Effects of Turnip (Animals : an open access journal from MDPI · 2021
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Harri Juhani SaarinenDepartment of Cardiology, Kanta-Häme Central Hospital, Hameenlinna, Finland.
Chaiyasit SittiwetUniversity of Helsinki and Helsinki University Central Hospital, Abdominal Center, Helsinki, Finland.
Piia SimonenUniversity of Helsinki and Helsinki University Central Hospital, Heart and Lung Center, Helsinki, Finland.
Markku J NissinenUniversity of Helsinki and Helsinki University Central Hospital, Abdominal Center, Helsinki, Finland.
Ulf-Håkan StenmanUniversity of Helsinki and Helsinki University Central Hospital, Clinical Chemistry, Helsinki, Finland.
Helena GyllingUniversity of Helsinki and Helsinki University Central Hospital, Internal Medicine, Helsinki, Finland.
Ari PalomäkiDepartment of Emergency Medicine, Kanta-Häme Central Hospital, Hameenlinna, Finland.
University of Helsinki · FIHelsinki University Hospital · FIKanta-Hämeen Keskussairaala · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We have earlier reported the reduction of total cholesterol, low-density lipoprotein (LDL) cholesterol and oxidized LDL caused by short-term modification of diet with cold-pressed turnip rapeseed oil (CPTRO) instead of butter. The aim of this supplementary study was to determine whether the beneficial effects resulted from altered cholesterol metabolism during the intervention.Thirty-seven men with metabolic syndrome (MetS) completed an open, randomized and balanced crossover study. Subjects' usual diet was supplemented with either 37.5 g of butter or 35 mL of CPTRO for 6-8 weeks. Otherwise normal dietary habits and physical activity were maintained without major variations. Serum non-cholesterol sterols were assayed with gas-liquid chromatography and used as surrogate markers of whole-body cholesterol synthesis and absorption efficiency. Serum proprotein convertase subtilisin/kexin type 9 (PCSK9) concentration was analyzed with Quantikine ELISA Immunoassay. Serum cholesterol synthesis markers and serum cholestanol (absorption marker), all as ratios to cholesterol, did not differ between the periods. Serum campesterol and sitosterol ratios to cholesterol were significantly increased after the administration of CPTRO resulting from the increased intake of 217 mg/day of plant sterols in CPTRO. Serum PCSK9 concentration did not differ between CPTRO and butter periods.The reduction in serum cholesterol by 7.2% after consumption of rapeseed oil could not be explained by changes in cholesterol absorption, synthesis or PCSK9 metabolism in MetS.ClinicalTrials.gov NCT01119690.

Indexed as

AdultAgedButterCholesterolHumansMaleMetabolic SyndromeMiddle AgedPlant OilsProprotein Convertase 9ButterCholesterolPCSK9 protein, humanPlant OilsProprotein Convertase 9AtherosclerosisCholesterolDietary FatsFatty Acids, MonounsaturatedPolyunsaturated Fatty Acids

Identifiers

PMID28801309
PMCPMC5800324
OpenAlexW2744349994

What OpenQuestion holds

Texttitle and abstract
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.